NCT03916250View on ClinicalTrials.gov

Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 23, 2019

Primary Completion Date

April 15, 2019

Study Completion Date

May 12, 2019

Conditions
Healthy
Interventions
DRUG

PF-06700841 cream

PF-06700841 will be applied topically

DRUG

White petrolatum

White petrolatum will be applied topically

Trial Locations (1)

532-0003

Medical Corporation Heishinkai OPHAC Hospital, Osaka

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY